| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5702141 | Practical Radiation Oncology | 2017 | 7 Pages |
Abstract
SBRT has an important role to play in treating early-stage NSCLC, particularly for medically inoperable patients with limited other treatment options. Shared decision-making with patients should be performed in all cases to ensure the patient understands the risks related to SBRT, the side effects, and the alternative treatments available.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Gregory M.M. MD, CM, FRCPC, FACR, Jessica MD, Meredith MBBS, John MD, Tomer Z. MD, Chris R. MD, Brian E. MD, Karen Latzka, Simon S. MB, ChB, FACR, Drew MD, MPH, Benjamin MD, Andreas MD, Michael MD, George MD, PhD, FRCPC, Shervin M. MD, MPH,